OBJECTIVE: To assess a shortened quality-of-life (QoL) measurement tool in a population with advanced HIV infection. DESIGN: Five domains (seven items) in a 12-item questionnaire (SF-12) were compared with those same domains in a 39-item questionnaire (SF-39). Data were collected using SF-39 in a randomized clinical trial for the prevention of cytomegalovirus disease. METHODS: The performance of SF-12 relative to SF-39 was evaluated within each domain by comparing QoL scores at baseline and over time, assessing the reliability and validity for both instruments, assessing item consistency and discrimination within instruments, and implementing event-time analyses that quantified dependence of the hazard for death and progression of disease (POD) on baseline values. RESULTS: Baseline measures are similar for both instruments, with high correlation within each domain. The slopes over time for the SF-12 and SF-39 domains are also similar. Both the SF-12 and SF-39 domains have satisfactory reliabilities and perfect discrimination. The hazard ratios for death and POD are similar for both instruments within a domain. All SF-12 and most SF-39 domains are highly predictive for death but are not highly predictive for POD. CONCLUSIONS: For the domains considered, SF-12 is a reasonable and effective replacement for SF-39 in studies of patients with advanced HIV disease. SF-12 reduces item redundancy and the burden of data requirements for both investigators and patients; consequently, it may improve compliance with form completion.
RCT Entities:
OBJECTIVE: To assess a shortened quality-of-life (QoL) measurement tool in a population with advanced HIV infection. DESIGN: Five domains (seven items) in a 12-item questionnaire (SF-12) were compared with those same domains in a 39-item questionnaire (SF-39). Data were collected using SF-39 in a randomized clinical trial for the prevention of cytomegalovirus disease. METHODS: The performance of SF-12 relative to SF-39 was evaluated within each domain by comparing QoL scores at baseline and over time, assessing the reliability and validity for both instruments, assessing item consistency and discrimination within instruments, and implementing event-time analyses that quantified dependence of the hazard for death and progression of disease (POD) on baseline values. RESULTS: Baseline measures are similar for both instruments, with high correlation within each domain. The slopes over time for the SF-12 and SF-39 domains are also similar. Both the SF-12 and SF-39 domains have satisfactory reliabilities and perfect discrimination. The hazard ratios for death and POD are similar for both instruments within a domain. All SF-12 and most SF-39 domains are highly predictive for death but are not highly predictive for POD. CONCLUSIONS: For the domains considered, SF-12 is a reasonable and effective replacement for SF-39 in studies of patients with advanced HIV disease. SF-12 reduces item redundancy and the burden of data requirements for both investigators and patients; consequently, it may improve compliance with form completion.
Authors: Judith A Cook; Jane K Burke-Miller; Dennis D Grey; Jennifer Cocohoba; Chenlong Liu; Rebecca M Schwartz; Elizabeth T Golub; Kathryn Anastos; Pamela J Steigman; Mardge H Cohen Journal: AIDS Behav Date: 2014-06
Authors: Darren J Clayson; Diane J Wild; Paul Quarterman; Isabelle Duprat-Lomon; Maria Kubin; Stephen Joel Coons Journal: Pharmacoeconomics Date: 2006 Impact factor: 4.981
Authors: Omary Ubuguyu; Olivia C Tran; Robert Douglas Bruce; Frank Masao; Cassian Nyandindi; Norman Sabuni; Sheryl McCurdy; Jessie Mbwambo; Barrot H Lambdin Journal: Int J Drug Policy Date: 2016-03-11
Authors: P Todd Korthuis; Mary Jo Tozzi; Vijay Nandi; David A Fiellin; Linda Weiss; James E Egan; Michael Botsko; Angela Acosta; Marc N Gourevitch; David Hersh; Jeffrey Hsu; Joshua Boverman; Frederick L Altice Journal: J Acquir Immune Defic Syndr Date: 2011-03-01 Impact factor: 3.731
Authors: Hyong Jin Cho; Julienne E Bower; Catarina I Kiefe; Teresa E Seeman; Michael R Irwin Journal: Brain Behav Immun Date: 2012-04-25 Impact factor: 7.217
Authors: Hyong Jin Cho; Teresa E Seeman; Julienne E Bower; Catarina I Kiefe; Michael R Irwin Journal: Biol Psychiatry Date: 2009-07-29 Impact factor: 13.382
Authors: Jennifer C Elliott; Ahnalee M Brincks; Daniel J Feaster; Deborah S Hasin; Carlos Del Rio; Gregory M Lucas; Allan E Rodriguez; Ank E Nijhawan; Lisa R Metsch Journal: Alcohol Alcohol Date: 2018-09-01 Impact factor: 2.826
Authors: Chidozie Emmanuel Mbada; Olaniyi Onayemi; Yewande Ogunmoyole; Olubusola Esther Johnson; Christopher O Akosile Journal: Health Qual Life Outcomes Date: 2013-06-26 Impact factor: 3.186